AstraZeneca
AZN
AZN
545 hedge funds and large institutions have $19B invested in AstraZeneca in 2019 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 185 increasing their positions, 196 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% less funds holding
Funds holding: 557 → 545 (-12)
2.6% less ownership
Funds ownership: 37.66% → 35.06% (-2.6%)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
545
Holding in Top 10
3
Calls
$134M
Puts
$107M
Top Buyers
| 1 | +$222M | |
| 2 | +$149M | |
| 3 | +$120M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$108M |
| 5 |
Primecap Management
Pasadena,
California
|
+$70.2M |
Top Sellers
| 1 | -$500M | |
| 2 | -$395M | |
| 3 | -$206M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$128M |
| 5 |
YCMGA
York Capital Management Global Advisors
New York
|
-$57.9M |